The future of oncology pharmacy: European Conference of Oncology Pharmacy 2018

Meier, Klaus; Astier, A.; Boşnak, Ahmet Sami; Goněc, Roman

doi:10.1097/op9.0000000000000020

Cited by 5 publications

(4 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pharmacists' role in the management of cancer continues to evolve as providers are challenged with medication shortages, rapid deployment of newlyapproved biosimilars and novel antineoplastics, development and implementation of precision medicine, and rising costs of immunotherapy, oral oncolytics, and cellular-based therapies. [1][2][3] Oncology pharmacists serve as integral members of the oncology interdisciplinary team and are responsible for providing comprehensive medication management, patient counseling, therapeutic plan development, formulary management, drug therapy evaluation, safe compounding and preparation of chemotherapy, and treatment-related toxicity monitoring. [4][5][6][7][8] Similar to many other subspecialties, student pharmacists are unlikely to receive adequate classroom education on these complex and everchanging topics.…”

Section: Introductionmentioning

confidence: 99%

Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students

Horn

Wells²,

Halford

2021

J Oncol Pharm Pract

View full text Add to dashboard Cite

Introduction The primary objective of this study was to evaluate the effectiveness of an autonomous oncology boot camp on Advanced Pharmacy Practice Experience (APPE) student knowledge. Secondary objectives included assessing student perception of the virtual learning experience and overall comfort level with the material. Methods APPE students rotating through our institution between November 2019 and March 2020 were voluntarily enrolled in a 4-hour oncology-focused boot camp, which included five PlayPosit (Denver, CO, USA) interactive video lectures embedded with case-based application questions followed by one comprehensive web-based Quandary (Victoria, BC, Canada) action-maze case. Student learning was measured by a pre- and post-intervention exam. A web survey tool (Qualtrics, Provo, UT, USA) collected student perceptions evaluating their comfort with oncology-specific drug knowledge and APPE rotations tasks. Results Fifty students enrolled in the oncology boot camp, with 100% completing the pre- and post-intervention assessments. Overall, pre-intervention exam scores (mean: 55.4%, SD: 21.8%) improved by 23.2% following the boot camp (mean: 78.6%, SD: 19.2%; p < 0.001). Students performed better on all 10 exam questions, with 6 questions showing a statistically significant improvement (p < 0.05). Forty-five students (90%) completed the perception surveys. Of those, 93% agreed that it effectively reinforced important oncology knowledge, 91% supported the autonomous design, and 82% would recommend the oncology boot camp for future students. Conclusion The boot camp proved to be a beneficial educational tool that enhanced student knowledge and confidence in navigating common oncology concepts. Students valued the ability to independently complete the activities and supported its continuation.

show abstract

Section: Introductionmentioning

confidence: 99%

Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students

Horn

Wells²,

Halford

2021

J Oncol Pharm Pract

View full text Add to dashboard Cite

show abstract

“…15 In addition, as pharmacists become more integrated into the cancer care patient journey they may be strategically positioned to become more involved in prescribing and adjusting supportive medications, developing guidelines, and leading research initiatives. 19 Strengths of our project include the gathering and expanding knowledge in an emerging field of pharmacy practice. This project provided a forum for pharmacists to openly share their current practice experiences.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Exploration of current pharmacy practice in cardio-oncology: Experiences & perspectives

Merali

Anwar

Boyd

et al. 2022

J Oncol Pharm Pract

View full text Add to dashboard Cite

Introduction Cardiovascular complications can occur in oncology patients secondary to certain cancer therapies. Pharmacists are involved in the care of oncology patients who are at risk of or experiencing cardiotoxicity related to their cancer therapy. Our study aimed to understand how pharmacists in Canada care to these patients and to explore their experiences, perceptions, and challenges. Methods Canadian pharmacists currently involved in the care of patients receiving cancer treatments and at risk of or experiencing cardiotoxicity were invited to participate in a 30-min telephone interview using an interview guide. A combination of inductive and deductive reasoning was applied using two coders who independently reviewed the transcribed interviews and identified key concepts and themes. Results Eight pharmacists were interviewed. Perceived benefits included sharing specialized knowledge and conducting safety assessments. Perceived challenges were the lack of role recognition and resources and fractured continuity of care. Proposed future directions were to play a more substantial role in direct medication management, creation of specific guidance and tools to support the clinical decision-making process, and to understand how pharmacists at other sites were providing care through the creation of a community of practice. Conclusions As patient-focused medication specialists, pharmacists help guide clinical decision-making, assess cardiac risk factors, and offer individualized education to meet the holistic needs of oncology patients at risk of or experiencing cardiotoxicities. The creation of a cardio-oncology community of practice may allow pharmacists with a common interest to connect, share learnings, and collaborate on how to continue to advance the delivery of care.

show abstract

“…The collated results of these will be provided in this article, which is a follow-up of the previous investigation into the future of oncology pharmacy. [11]…”

Section: Introductionmentioning

confidence: 99%

Beliefs and perspectives on the future of oncology pharmacy—collated results of member surveys of the European Society of Oncology Pharmacy

Crul¹,

Meier²,

Meier³

2022

European Journal of Oncology Pharmacy

Self Cite

View full text Add to dashboard Cite

Introduction:The European Society of Oncology Pharmacy (ESOP) has nearly 4000 members in 66 countries. Periodically, the needs and interests of the members as well as the predictions of the members for the development of the profession of oncology pharmacy are mapped by the board of the Society. The aim of these inquiries is to help focus the Societies' advocacy works, knowledge exchange, and scientific and educational programs into those areas where the members deem this most needed.Methods: One survey into the future of oncology pharmacy was held in 12 individual countries during a national meeting on the topic of oncology pharmacy. In this survey, the forecasts of the members were researched. A second survey was held under the full membership to identify the topics of most interest within the broader field of oncology care.Results: Five hundred ninety-five colleagues responded to the future of oncology pharmacy survey and 757 to the topics of interest survey. Participating respondents came from 53 individual countries. Combined, the results show that both clinical care (in multiprofessional treatment teams) and education are important areas for the Society to continue paying attention to. The other important aspect of oncology pharmacy, which includes the practical and safety aspects of compounding, remains of great interest, especially regarding technical innovations such as robotics.Conclusion: ESOP will remain focused on its initial aim: to support optimal treatment for patients with cancer. The globally collated data from the two surveys show that both the clinical and the practical sides of the profession deserve continuing advancement.

show abstract

The future of oncology pharmacy: European Conference of Oncology Pharmacy 2018

Cited by 5 publications

References 2 publications

Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students

Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students

Exploration of current pharmacy practice in cardio-oncology: Experiences & perspectives

Beliefs and perspectives on the future of oncology pharmacy—collated results of member surveys of the European Society of Oncology Pharmacy

Contact Info

Product

Resources

About